CCI approves GSK, Pfizer consumer healthcare JV formation

After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news